Summary
For Year 2026-27, iSERA Lifesciences reports the following shareholding: Total Promoters at 58.63%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 0%, and Retail at 41.37%. This breakdown provides a quick snapshot of ownership distribution for iSERA Lifesciences in 2026-27.
iSERA Lifesciences FAQs
As of 05-2026, the promoter shareholding in iSERA Lifesciences stands at 58.63% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of iSERA Lifesciences is 0% and 0% respectively.
The retail shareholding of the iSERA Lifesciences is 41.37%.
Changes in shareholding patterns of iSERA Lifesciences can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of iSERA Lifesciences are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
iSERA Lifesciences Associated Pages
